Figure 5
![Figure 5](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1471-2164-16-S7-S2/MediaObjects/12864_2015_Article_7196_Fig5_HTML.jpg)
Classification of high-grade serous ovarian cancer patients. The patients diagnosed with high-grade serous ovarian cancer were classified using a data-driven method for statistically novel biomarkers (A) FZD1and (B) HGFand common biomarkers (C) COL3A1and (D) EDNRA. Log-rank tests were used to assess the survival statistical significance of the two patient subgroups. Expr: expression.